Next Article in Journal
Response to Anti-PD1/L1 Antibodies in Advanced Urothelial Cancer in the ‘Real-Life’ Setting
Next Article in Special Issue
Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo
Previous Article in Journal
From Snake Venoms to Therapeutics: A Focus on Natriuretic Peptides
Previous Article in Special Issue
Optimization of the Pharmacokinetic Profile of [99mTc]Tc-N4-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(9), 1155; https://doi.org/10.3390/ph15091155
Action Date Notes Link
article xml file uploaded 16 September 2022 13:15 CEST Original file -
article xml uploaded. 16 September 2022 13:15 CEST Update https://www.mdpi.com/1424-8247/15/9/1155/xml
article pdf uploaded. 16 September 2022 13:15 CEST Version of Record https://www.mdpi.com/1424-8247/15/9/1155/pdf
article supplementary file uploaded. 16 September 2022 13:15 CEST - https://www.mdpi.com/1424-8247/15/9/1155#supplementary
article html file updated 16 September 2022 13:16 CEST Original file -
article html file updated 28 February 2023 13:57 CET Update https://www.mdpi.com/1424-8247/15/9/1155/html
Back to TopTop